The proposed mechanisms for the role of 25-hydroxyvitamin D in improving insulin resistance in obesity include reducing inflammation, enhancing peripheral and hepatic glucose uptake, and regulating insulin synthesis and secretion by pancreatic β cells through direct and indirect pathways (44). The gene discussed is INS; the disease is obesity due to melanocortin 4 receptor deficiency.